Cargando…

Expression of USP22 and Survivin is an indicator of malignant behavior in hepatocellular carcinoma

Detalles Bibliográficos
Autores principales:	Tang, Bo, Liang, Xingsi, Tang, Fang, Zhang, Jing, Zeng, Sien, Jin, Shengjian, Zhou, Lihua, Kudo, Yasusei, Qi, Guangying
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2023
Materias:	Retraction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9937686/ https://www.ncbi.nlm.nih.gov/pubmed/36799153 http://dx.doi.org/10.3892/ijo.2023.5485

Ejemplares similares

Expression of USP22 and the chromosomal passenger complex is an indicator of malignant progression in oral squamous cell carcinoma
por: Liu, Tian, et al.
Publicado: (2019)

PARP6 acts as a tumor suppressor via downregulating Survivin expression in colorectal cancer
por: Qi, Guangying, et al.
Publicado: (2016)

High USP22 expression indicates poor prognosis in hepatocellular carcinoma
por: Tang, Bo, et al.
Publicado: (2015)

The relationship between the expression of USP22, BMI1, and EZH2 in hepatocellular carcinoma and their impacts on prognosis
por: Zhai, Run, et al.
Publicado: (2016)

[Retracted] RNA interference‑mediated USP22 gene silencing promotes human brain glioma apoptosis and induces cell cycle arrest
por: Li, Zhao Hui, et al.
Publicado: (2023)

The Role of Deubiquitinating Enzyme in Head and Neck Squamous Cell Carcinoma
por: Jin, Shengjian, et al.
Publicado: (2022)

Retraction Note: HOXA7 plays a critical role in metastasis of liver cancer associated with activation of Snail
por: Tang, Bo, et al.
Publicado: (2023)

Retraction Note: The POU2F1/miR-4490/USP22 axis regulates cell proliferation and metastasis in gastric cancer
por: Xiao, Yizhi, et al.
Publicado: (2022)

MicroRNA-466 inhibits the aggressive behaviors of hepatocellular carcinoma by directly targeting metadherin
por: Jia, Chen, et al.
Publicado: (2022)

[Retracted] Resistance to the mTOR inhibitor everolimus is reversed by the downregulation of survivin in breast cancer cells
por: Taglieri, Ludovica, et al.
Publicado: (2023)

Retraction of “Lidocaine has antitumor effect on hepatocellular carcinoma via the circ_DYNC1H1/miR-520a-3p/USP14 axis”
por: Liu, Hua, et al.
Publicado: (2022)

MicroRNA-155-3p promotes hepatocellular carcinoma formation by suppressing FBXW7 expression
por: Tang, Bo, et al.
Publicado: (2016)

USP22 upregulates ZEB1-mediated VEGFA transcription in hepatocellular carcinoma
por: Zeng, Kai, et al.
Publicado: (2023)

Overexpression of CTNND1 in hepatocellular carcinoma promotes carcinous characters through activation of Wnt/β-catenin signaling
por: Tang, Bo, et al.
Publicado: (2016)

[Retracted] KIF22 promotes bladder cancer progression by activating the expression of CDCA3
por: Li, Kai, et al.
Publicado: (2023)

Retraction Note: LNCAROD enhances hepatocellular carcinoma malignancy by activating glycolysis through induction of pyruvate kinase isoform PKM2
por: Jia, Guizhi, et al.
Publicado: (2023)

MicroRNA-22 inhibits cell growth and metastasis in breast cancer via targeting of SIRT1
por: Zou, Quanqing, et al.
Publicado: (2021)

USP22 regulates lipidome accumulation by stabilizing PPARγ in hepatocellular carcinoma
por: Ning, Zhen, et al.
Publicado: (2022)

Retracted: DNA Topoisomerase II-α Regulated by miR-22-5p Promotes Hepatocellular Carcinoma Invasion and Migration through the Hippo Pathway
por: Longevity, Oxidative Medicine and Cellular
Publicado: (2023)

USP22 knockdown enhanced chemosensitivity of hepatocellular carcinoma cells to 5-Fu by up-regulation of Smad4 and suppression of Akt
por: Zhang, Jing, et al.
Publicado: (2017)

[Retracted] Downregulation of δ opioid receptor by RNA interference enhances the sensitivity of BEL/FU drug‑resistant human hepatocellular carcinoma cells to 5‑FU
por: Tang, Bo, et al.
Publicado: (2023)

LINC02476 Promotes the Malignant Phenotype of Hepatocellular Carcinoma by Sponging miR-497 and Increasing HMGA2 Expression [Retraction]
Publicado: (2022)

microRNA-485 inhibits the malignant behaviors of retinoblastoma by directly targeting Wnt3a
por: Lyu, Xueman, et al.
Publicado: (2022)

Inhibition of USP2 Enhances TRAIL-Mediated Cancer Cell Death through Downregulation of Survivin
por: Lee, Tak Gyeom, et al.
Publicado: (2023)

Retracted: Effects of Circ_0109046 Regulating Mir-338-3p on the Malignant Behavior of A2780 Cells
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023)

USP22 promotes IRF3 nuclear translocation and antiviral responses by deubiquitinating the importin protein KPNA2
por: Cai, Zeng, et al.
Publicado: (2020)

Retracted: MicroRNA-143-3p/TBX3 Axis Represses Malignant Cell Behaviors in Bladder Cancer
por: Methods in Medicine, Computational and Mathematical
Publicado: (2023)

[Retracted] MicroRNA‑574‑3p inhibits the malignant behavior of liver cancer cells by targeting ADAM28
por: Zha, Zhongming, et al.
Publicado: (2023)

microRNA-944 Inhibits the Malignancy of Hepatocellular Carcinoma by Directly Targeting IGF-1R and Deactivating the PI3K/Akt Signaling Pathway [Retraction]
Publicado: (2021)

Invasion-Related Factors as Potential Diagnostic and Therapeutic Targets in Oral Squamous Cell Carcinoma—A Review
por: Siriwardena, Samadarani B. S. M., et al.
Publicado: (2018)

Retraction Note: miR-3928v is induced by HBx via NF-κB/ EGR1 and contributes to hepatocellular carcinoma malignancy by down-regulating VDAC3
por: Zhang, Qiaoge, et al.
Publicado: (2022)

Survivin 2α: a novel Survivin splice variant expressed in human malignancies
por: Caldas, Hugo, et al.
Publicado: (2005)

Retracted: MicroRNA-139-5p Suppresses Cell Malignant Behaviors in Breast Cancer through Targeting MEX3A
por: Methods in Medicine, Computational and Mathematical
Publicado: (2023)

Retraction Notice to: LINC01234/MicroRNA-31-5p/MAGEA3 Axis Mediates the Proliferation and Chemoresistance of Hepatocellular Carcinoma Cells
por: Chen, Yunhao, et al.
Publicado: (2022)

MicroRNA-511 inhibits malignant behaviors of breast cancer by directly targeting SOX9 and regulating the PI3K/Akt pathway
por: Zhao, Yuying, et al.
Publicado: (2022)

Retraction of “MICAL2 Mediates p53 Ubiquitin Degradation through Oxidating p53 Methionine 40 and 160 and Promotes Colorectal Cancer Malignance”
por: Lu, Jinping, et al.
Publicado: (2021)

Upregulation of USP22 and ABCC1 during Sorafenib Treatment of Hepatocellular Carcinoma Contribute to Development of Resistance
por: Chang, Yung-Sheng, et al.
Publicado: (2022)

Circulating CD9+/GFAP+/survivin+ exosomes in malignant glioma patients following survivin vaccination
por: Galbo, Phillip M., et al.
Publicado: (2017)

DICER1-AS1 Promotes the Malignant Behaviors of Colorectal Cancer Cells by Regulating miR-296-5p/STAT3 Axis [Retraction]
Publicado: (2023)

[Retracted] miR‑365 induces hepatocellular carcinoma cell apoptosis through targeting Bcl‑2
por: Li, Mingfei, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_m13lmra67v8t8qp9fdj48k9du7